P667: RISK OF PROGRESSION IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA PATIENTS ELIGIBLE FOR TYROSINE KINASE INHIBITOR DISCONTINUATION: FINAL ANALYSIS OF THE TFR-PRO STUDY

• Giovanni Paolo Maria Zambrotta,
• Sarit Assouline,
• Franck E. Nicolini,
• Elisabetta Abruzzese,
• Ester Pungolino,
• Maria Cristina Miggiano,
• Chiara Elena,
• Alberto Alvarez Larran,
• Ana Triguero Moreno,
• Alessandra Iurlo,
• Cristina Bucelli,
• Francesca Lunghi,
• Isabella Capodanno,
• Margherita Maffioli,
• Sara Galimberti,
• Giovanni Caocci,
• Fabio Stagno,
• Susanne Saussele,
• Carmen Fava,
• Philipp Le Coutre,
• Massimiliano Bonifacio,
• Veronica Guglielmana,
• Federica Colombo,
• Laura Antolinni,
• Carlo Gambacorti-Passerini

Affiliations

Giovanni Paolo Maria Zambrotta

1 University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy

Sarit Assouline

3 Jewish General Hospital, McGill University, Department of Medicine and Oncology, Montreal, Canada

Franck E. Nicolini

4 Hématologie clinique & INSEM U1052, Centre Léon Bérard, Lyon, France

Elisabetta Abruzzese

5 Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Roma, Italy

Ester Pungolino

6 ASST Grande Ospedale Metropolitano Niguarda, Division of Hematology, Milano, Italy

Maria Cristina Miggiano

7 San Bortolo Hospital, Azienda ULSS8 “Berica” di Vicenza, Hematology Department, Vicenza, Italy

Chiara Elena

8 Foundation IRCCS Policlinico San Matteo, University of Pavia, Department of Hematology Oncology, Pavia, Italy

Alberto Alvarez Larran

9 Hospital Clínic, Hematology Department, Barcelona, Spain

Ana Triguero Moreno

9 Hospital Clínic, Hematology Department, Barcelona, Spain

Alessandra Iurlo

10 Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy

Cristina Bucelli

11 Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Hematology Division, Milano, Italy

Francesca Lunghi

12 IRCCS San Raffaele Scientific Institute and Vita-Salute Hospital, Department of Onco-Haematology - Haematology and Bone Marrow Transplantation, Milano, Italy

Isabella Capodanno

13 Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Hematology Unit, Reggio Emilia, Italy

Margherita Maffioli

14 Hematology, Ospedale di Circolo e Fondazione Macchi, University of Insubria, ASST Sette Laghi, Varese, Italy

Sara Galimberti

15 Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Azienda ospedaliera Pisana, Pisa, Italy

Giovanni Caocci

16 Hematology Unit, Cagliari University, Businco Hospital, Cagliari, Italy

Fabio Stagno

17 A.O.U. “Policlinico-Vittorio Emanuele”, University of Catania, Division of Hematology and Bone Marrow Transplantation Unit, Catania, Italy

Susanne Saussele

18 University Hospital Mannheim, Heidelberg University, Department of Hematology and Oncology, Mannheim, Germany

Carmen Fava

19 A.O. Ordine Mauriziano di Torino, Hematology Division, Torino, Italy

Philipp Le Coutre

20 Charité Campus Mitte, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Massimiliano Bonifacio

21 University of Verona, Department of Medicine, Section of Hematology, Verona, Italy

Veronica Guglielmana

1 University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy

Federica Colombo

1 University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy

Laura Antolinni

1 University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy

Carlo Gambacorti-Passerini

1 University of Milano-Bicocca, Department of Medicine and Surgery, Monza, Italy